INTRODUCTION: Access to Nicotine Replacement Therapy (NRT) is a key public health intervention to reduce smoking. We assessed prevalence and correlates of use of NRT in Ontario, where NRT is available without prescription. METHODS: Participants were a representative sample of 2262 adult smokers in the Ontario Tobacco Survey cohort. Prospectively measured use of NRT over a 6-month period was reported in relation to smoking behaviour and history, attempts to quit, receipt of other supports for cessation supports and attitudes toward NRT. RESULTS: Overall, 11% of smokers used NRT over the six-month follow-up period. Prevalence was 25% among the 27% of smokers matching clinical guidelines that recommend NRT as a therapeutic option, and low among smokers not trying to quit. CONCLUSION: With increasing accessibility of NRT, further surveillance and research are warranted to determine the impact of the reach and benefits of NRT, considering both the general and targeted smoking populations.
INTRODUCTION: Access to Nicotine Replacement Therapy (NRT) is a key public health intervention to reduce smoking. We assessed prevalence and correlates of use of NRT in Ontario, where NRT is available without prescription. METHODS:Participants were a representative sample of 2262 adult smokers in the Ontario Tobacco Survey cohort. Prospectively measured use of NRT over a 6-month period was reported in relation to smoking behaviour and history, attempts to quit, receipt of other supports for cessation supports and attitudes toward NRT. RESULTS: Overall, 11% of smokers used NRT over the six-month follow-up period. Prevalence was 25% among the 27% of smokers matching clinical guidelines that recommend NRT as a therapeutic option, and low among smokers not trying to quit. CONCLUSION: With increasing accessibility of NRT, further surveillance and research are warranted to determine the impact of the reach and benefits of NRT, considering both the general and targeted smoking populations.
Authors: Smita Pakhale; Justine Baron; Michael A Armstrong; Avanti Garde; Robert D Reid; Gonzalo Alvarez; Debbie Aitken; Kerri-Anne Mullen; George Wells; Andrew Pipe Journal: Can Respir J Date: 2015-02-03 Impact factor: 2.409
Authors: Susan J Bondy; J Charles Victor; Lori M Diemert; Graham C Mecredy; Michael Chaiton; K Stephen Brown; Joanna E Cohen; Paul W McDonald; Roberta Ferrence; John M Garcia; Peter Selby; Robert Schwartz Journal: Nicotine Tob Res Date: 2012-12-10 Impact factor: 4.244
Authors: Jennifer Kahende; Ann Malarcher; Lucinda England; Lei Zhang; Paul Mowery; Xin Xu; Varadan Sevilimedu; Italia Rolle Journal: PLoS One Date: 2017-02-16 Impact factor: 3.240